Refractory GERD : case presentation and discussion

Similar documents
GERD DIAGNOSIS & TREATMENT DISCLOSURES 4/18/2018

In the Name of God. Refractory GERD

GERD: How to. Failures

Unmet Needs in the Management of Gastroesophageal Reflux Disease

What can you expect from the lab?

GERD: A linical Clinical Clinical Update Objectives

GERD: 2014 Dilemmas and Solutions. Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University

NEGATIVE ENDOSCOPY, What is the Diagnosis and Treatment?

Refractory GERD: What s a Gastroenterologist To Do?

ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease

Burning Issues in Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease in Infants and Children

Dysphagia. Conflicts of Interest

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

Title: Comparison of esophageal motility in gastroesophageal reflux disease with and without globus sensation

Comparison of esophageal motility in gastroesophageal reflux disease with and without globus sensation

Gastroesophageal Reflux Disease (GERD)

GERD. Gastroesophageal reflux disease, or GERD, occurs when acid from the. stomach backs up into the esophagus. Normally, food travels from the

127 Chapter 1 Chapter 2 Chapter 3

Esophageal Motility Disorders. Disclosures

Refractory GERD. Kenneth R. DeVault, MD, FACG President American College of Gastroenterology Chair Department of Medicine Mayo Clinic Florida

Supplementary appendix

Speaker disclosure. Objectives. GERD: Who and When to Treat 7/21/2015

Hold the Wrap! There is so much more to be done!

Surgical Evaluation for Benign Esophageal Disease. Kimberly Howard, PA-C, MHS Duke University Medical Center April 7, 2018

WHAT IS GASTROESOPHAGEAL REFLUX DISEASE (GERD)?

Achalasia: Inject, Dilate, or Surgery?

Manometry Conundrums

Definition of GERD American College of Gastroenterology

Disclosures. Heartburn and Barrett s Esophagus. Heartburn and Barrett s Esophagus. GERD is common in the U.S. None

Combined multichannel intraluminal impedance and. Characteristics of Consecutive Esophageal Motility Diagnoses After a Decade of Change

GERD: Pitfalls and Pearls

Approach to Patients with Non-Cardiac Chest Pain

J Neurogastroenterol Motil, Vol. 25 No. 1 January, 2019

Nexium 24HR Pharmacy Training

GASTROESOPHAGEAL REFLUX

High Resolution Impedance Manometry (HRiM ) Swallow Atlas

ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd

Myogenic Control. Esophageal Motility. Enteric Nervous System. Alimentary Tract Motility. Determinants of GI Tract Motility.

Esophageal Motility. Alimentary Tract Motility

David Markowitz, MD. Physicians and Surgeons

Gastroesophageal Reflux Disease, Paraesophageal Hernias &

Catherine Kerschen DO, FACOI Michigan State University College of Osteopathic Medicine

Putting Chronic Heartburn On Ice

PeriOperative Concerns for Anti Reflux Procedure Patients

A CURIOUS CASE OF HYPERTENSIVE LES. Erez Hasnis Department of Gastroenterology Rambam Health Care Campus

Index. Note: Page numbers of article titles are in boldface type.

Functional Heartburn and Dyspepsia

Oesophageal Disorders

How to Manage Refractory Heartburn

Modern Evaluation for Antireflux Surgery

ENDOLUMINAL THERAPIES FOR GERD. University of Colorado Department of Surgery Grand Rounds March 31st, 2008

An Overview on Pediatric Esophageal Disorders. Annamaria Staiano Department of Translational Medical Sciences University of Naples Federico II

Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure

Prevalence and Clinical Characteristics of Refractoriness to Optimal Proton Pump Inhibitor Therapy in Non-erosive Reflux Disease

Findings of impedance ph-monitoring in patients with atypical gastroesophageal reflux symptoms

9/18/2015. Disclosures. Objectives. Dysphagia Sherri Ekobena PA-C. I have no relevant financial interests to disclose I have no conflicts of interest

PREPARING FOR REFLUX TESTING. Digitrapper Reflux Testing System

Options for Gastroesophageal Reflux: Endoluminal. W. Scott Melvin, M.D. Montefiore Medical System and the Albert Einstein School of Medicine

4/24/2015. History of Reflux Surgery. Recent Innovations in the Surgical Treatment of Reflux

UPDATES IN MOTILITY TESTING. Disclosure

GERD is a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications

Obesity Is Associated With Increased Transient Lower Esophageal Sphincter Relaxation. Introduction. Predisposing factor. Introduction.

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal reflux disease (GERD) is a common chronic

The role of the modified barium swallow study & esophagram in patients with GERD/Globus sensation

La tasca acida nella MRGE: aspetti patogenetici e terapeutici

QUICK QUERIES. Topical Questions, Sound Answers

Health-related quality of life and physiological measurements in achalasia

GASTROESOPHAGEAL REFLUX DISEASE. William M. Brady

Gastroesophageal reflux (GER) Gastroesophageal reflux (GER), the passage of gastric contents into the esophagus, is a normal physiologic process that

Eosinophilic Esophagitis. Another Reason Not to Swallow

Achalasia is a rare disease with an annual incidence estimated REVIEWS. Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia

Number of studies. Endoscopic finding. Number of subjects. Pooled prevalence 95% CI

The Impact of Gender on the Symptom Presentation and Life Quality of Patients with Erosive Esophagitis and Non-Erosive Reflux Disease

SASKATCHEWAN REGISTERED NURSES ASSOCIATION

Maximizing Outcome of Extraesophageal Reflux Disease. (GERD) is often accompanied

PREPARING FOR REFLUX TESTING. Bravo Reflux Testing System. A simple way to evaluate your gastroesophageal reflux symptoms

EGD. John M. Wo, M.D. University of Louisville July 3, 2008

Optimal Management of GERD with Dexlansoprazole - Extended plasma concentration and dosing flexibility with a dual delayed release PPI

Gastroesophageal reflux in children

TBURN TBURN BURN ARTBURN EARTBURN EART HEARTBURN: HOW TO GET IT OFF YOUR CHEST

Guiding Principles. Trans-oral Incisionless Fundoplication (TIF) for GERD: When, Why & How 4/6/18

Falk Symposium, , , Portorož. Physiology of Swallowing and Anti-Gastroesophageal. Reflux-Mechanisms. Mechanisms: C.

11/19/2012. Comparison between PPIs G CELL. Risk ratio (95% CI) Patient subgroup. gastrin. S-form of omeprazole. Acid sensitive. coated.

The PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia. Disclosures

Outline. Outline. Definition. Asthma, GERD and Laryngeal Pharyngeal Reflux (LPR) Definitions

INSIGHT HRiM. Simplify the Complexities of. High Resolution Impedance Manometry System

Achalasia: Classic View

High Resolution Manometry: A new perspective on esophageal motility disorders. Chris Andrews & Bill Paterson

Disclosures. Proton Pump Inhibitors Deprescribing? Deprescribing PPI Objectives. Deprescribing. Proton Pump Inhibitors (PPI) 5/28/2018.

Esophageal Eosinophilia and Eosinophilic Esophagitis. Bible Class 09. Mai 2018

Understanding GERD. & Stretta Therapy. GERD (gĕrd): Gastroesophageal Reflux Disease

High Resolution Esophageal Manometry

The Frequency of Gastroesophageal Reflux Disease in Nutcracker Esophagus and the Effect of Acid-Reduction Therapy on the Motor Abnormality

Two Distinct Types of Hypercontractile Esophagus: Classic and Spastic Jackhammer

Motility characteristics in the transition zone in Gastroesophageal Reflux Disease (GORD) patients

BRAVO. ph Monitoring System. A patient-friendly test for heartburn

Survey of findings in patients having persistent heartburn on proton pump inhibitor therapy

ACID REFLUX & GERD: The Unsettling Reality in Canada

Transcription:

Refractory GERD : case presentation and discussion Ping-Huei Tseng National Taiwan University Hospital May 19, 2018

How effective is PPI based on EGD? With GERD symptom 75% erosive 25% NERD Endoscopy 81% response 19% not response 37% response 63% not response PPI treatment Lee YC, et al. J Gastroenterol Hepatol. 2007;22:1286-92 Tseng PH, et al. J Clin Gastroenterol. 2009;43:920-5

Refractory GERD (PPI failure ) Persistent reflux symptoms or endoscopic visible lesions despite of standard (or double) dose PPI for at least 2 (or 3) months

How common is PPI failure? Persistent symptoms 30-35% of patients with EE 50-55% of patients with NERD Regurgitation > heartburn Atypical > typical symptoms Persistent esophagitis 10-15 % of patients with LA A/B 15-30% of patients with LA C/D Clin Gastroenter Hepatol 2012;10:612-9

Case 1 24 male Heartburn and acid regurgitation for 1 year Not related to meals heartburn when lying flat at night time Poor response to various PPI Smoking -, drinking - BMI: 20.4 EGD: minimal breaks Referred for MII-pH evaluation

Multichannel Intraluminal Impedance and ph monitoring (MII-pH) Impedance: ph: refluxate presence distribution and extent bolus clearing Acidic: ph<4 Weakly acidic: ph 4-7 Non-acidic: ph>7 Symptom association: Symptom index (SI) Symptom association probability (SAP)

MII-pH: equipment and patient diary

24-h MII-pH (on PPI) 8 Many weakly acidic refluxes 24-h ph: ph<4: 0.1% (<1.2%) Demeester score: 1.7 (<14.7) 24-h impedance: Reflux: 85 (<48) Acidic: 4 (<10) Weakly /non-acidic: 67/7 (<35) Symptom association: SI: 0% (>50%), SAP: 0% (95%)

MII-pH: non-acid reflux

Non-Acid Reflux: clinical significance 144 pts refractory to PPI bid Symptom index (SI) Symptoms due to Non-acid reflux: 37% Acid reflux: 11% No association: 52% Mainie et al. Gut 2006;55:1398

Case 2 49 male Acid regurgitation for 7 years Heartburn, mid-sternal pain, globus sensation, poor digestion and postprandial fullness. Sleep disturbance (+) Easy anxiety. He has visited many doctors and undergone EGD several times but no obvious esophageal inflammation was found. PPI has been tried with only partial responses. Smoking -, alcohol -, coffee - BH: 158 cm, BW: 47 kg, BMI: 18.8 kg/m 2

24-h MII-pH (on PPI) Hypersensitive to weakly acidic refluxes 24-h ph: ph<4: 0% (<4.2%) Demeester score: 0.2 (<14.7) 24-h impedance: Reflux: 37 (<75) Acidic: 1, weakly acidic: 36 Symptom association: SI: 63% (>50%), SAP: 100% (95%)

Course of management Lansoprazole 30 mg bid and imipramine 25 mg hs were prescribed. Diet and lifestyle modification. However, no obvious symptom improvement was noted after 4 months. Follow-up EGD showed only mild gastritis.

Case 3: 68 male Globus, throat clearing, cough Smoking (-), drinking (-) BMI: 23.3 ENT: normal EGD: normal RDQ=6; GerdQ=6; RSI=19

24-h MII-pH (off PPI) GERD!! 24-h ph: ph<4: 6.2% (<4.2%) Demeester score: 21.7 (<14.7) 24-h impedance: Reflux: 90 (<75) Acidic: 56, weakly acidic: 34 Symptom association: SI:78 % (>50%), SAP:100% (95%)

Prevalences of extraesophageal symptoms among GERD patients ProGERD study: 6215 patients with EE and NERD Eextraesophageal manifestations: 32.8% Non-cardiac chest pain: 14.5% chronic cough: 13.0% laryngeal disorders: 10.4% Asthma: 4.8% ERD > NERD Aliment Pharmacol Ther 2003;17:1515-1520

Prevalences of extraesophageal symptoms among GERD patients (Korean) ERD > NERD N=1712 J Neurogastroenterol Motil. 2014 Jan;20(1):87-93

Extra-esophageal manifestations Characteristics Non-specific, subjective Persistent, less episodic Higher dose, longer duration and poor response to PPI Other conditions: smoking, allergy, neurogenic, psychogenic Clinical impact: QoL Medical cost Curr Opin Gastroenterol 2010; 26:389-94 Am J Gastroenterol 2013; 108:905 911

GERD and esophageal motility disorder Associated esophageal motility disorder Absent contractility (scleroderma esophagus) Ineffective esophageal motility (IEM) Hypotensive LES Clinical manifestations High grade erosive esophagitis Barrett s esophagus Esophageal stenosis Dysphagia World J Gastrointest Pharmacol Ther 2014; 5: 86-96

Case 4 : 33 female Acid regurgitation for 7 years Esp. waking up in the morning, bitter taste in the mouth. Heartburn also accompanied. She has visited many doctors and undergone EGD several times but only mild esophageal inflammation was found. PPI bid has been tried with no obvious response Smoking -, alcohol -, coffee - BH: 168 cm, BW: 52 kg, BMI: 18.4 kg/m 2

High resolution manometry (HRM) Ineffective esophageal motility (IEM) with 70% failed contractions!!

24-h MII-pH (on PPI) No pathological reflux by ph and impedance monitoring 24-h ph: ph<4: 0% (<4.2%) Demeester score: 0.2 (<14.7) 24-h impedance: Reflux: 0 Symptom association: negative

Course of management Dexilant 60 mg qd and mosapride were prescribed. Diet and lifestyle modification. Education and reassurance was also given. However, she only have minimal symptom improvement PPI may be limited for reflux patients with esophageal dysmotility!

Mrs Lee, 64 female Dermatomyositis Smoking/alcohol (-) ; BMI: 19.4 Acid regurgitation at night, especial after 0.5-1 hr going to bed Poor sleep Swallowing disturbance(+) EGD: Reflux esophagitis, LA Gr. D Refractory acid reflux under PPI Referred for pre-op evaluation

High resolution manometry (HRM) Absent contractility with 100% failed peristalsis and hypotensive LES!!

24-h Impedance-pH (on PPI) Extreme low impedance at lower esophagus: fluid accumulation Esophageal acid exposure: 17.3% (<4.2%) Supine: 39.2% upright: 1.1% Gastric ph: median 2.7 Scleroderma esophagus!!

53F, acid reflux for 1.5 years Mild dysphagia EGD: GERD A? PPI with poor response Aggravated dysphagia, weight loss 8 kg/1 yr Resting pressure: 31 mmhg IRP-4s: 7.7 mmhg 100% failed contraction 30% panesophageal pressurization Achalasia, type II

Ms Lin, 32 female Acid reflux, heartburn, hoarseness Smoking (-), drinking (-) BMI: 45.2 Upper endoscopy: normal Poor response to PPI Pre-OP evaluation RDQ=40; GerdQ=11; RSI=28

24-h MII-pH (off PPI) No GERD!! Functional heartburn!! 24-h ph: ph<4: 0.7% (<4.2%) Demeester score: 2.2 (<14.7) 24-h impedance: Reflux: 35 (<75) Acidic: 13, weakly acidic: 20 Gas reflux: 141 Symptom association: 5 episodes of chest pain SI: 0% (>50%), SAP: 0% (95%)

GERD subgroups: endoscopic and MII-pH categorization Nat. Rev. Gastroenterol Hepatol 2013;10:371 80

Patients with refractory reflux symptoms N=106; all received MII-pH and gastroscopy (excluding esophagitis and BE) Hiatal hernia: 46 (43%) Neurogastroenterol Motil 2015; 27: 1267 73

Algorithm for refractory GERD GERD Symptoms EGD Barrett s, malignancy Response + PPI Diet and life style modification Maintenance, On demand Response MII-pH + manometry (HRM) Motility disorder Acid reflux Weakly acid/ non-acid reflux Negative Specific Tx compliance, Dosing, timing, change Rx, H2RA Baclofen, surgery, endoscopic Tx Pain modulator, Psychological consultation 33 Modified from Fass CGH 2008

2017 年新增健保給付項目 多管腔食道內阻抗及酸鹼度測定

Take Home Message Refractory reflux symptoms are increasingly common in our clinical practice The pathogenesis of refractory reflux symptoms is complex, ranging from mechanically impaired barrier to dysmotility to visceral hypersensitivity Application of esophageal motility studies, including HRM and MII-pH, may help to clarify the underlying mechanism of refractory reflux symptoms and tailor further treatment strategies (personalized medicine)

Thank You for Your Attention!!